Gut microbiome and health: mechanistic insights
2022/02/01 by Willem M de Vos, Willem M. de Vos, Herbert Tilg +3 · 52 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Diet and metabolism studies #Dietary Effects on Health #Gut microbiota and health
paper · pdf · doi:10.1136/gutjnl-2021-326789
openalex publication_date 2022/02/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
Abstract
The gut microbiota is now considered as one of the key elements contributing to the regulation of host health. Virtually all our body sites are colonised by microbes suggesting different types of crosstalk with our organs. Because of the development of molecular tools and techniques (ie, metagenomic, metabolomic, lipidomic, metatranscriptomic), the complex interactions occurring between the host and the different microorganisms are progressively being deciphered. Nowadays, gut microbiota deviations are linked with many diseases including obesity, type 2 diabetes, hepatic steatosis, intestinal bowel diseases (IBDs) and several types of cancer. Thus, suggesting that various pathways involved in immunity, energy, lipid and glucose metabolism are affected.In this review, specific attention is given to provide a critical evaluation of the current understanding in this field. Numerous molecular mechanisms explaining how gut bacteria might be causally linked with the protection or the onset of diseases are discussed. We examine well-established metabolites (ie, short-chain fatty acids, bile acids, trimethylamine N-oxide) and extend this to more recently identified molecular actors (ie, endocannabinoids, bioactive lipids, phenolic-derived compounds, advanced glycation end products and enterosynes) and their specific receptors such as peroxisome proliferator-activated receptor alpha (PPARα) and gamma (PPARγ), aryl hydrocarbon receptor (AhR), and G protein-coupled receptors (ie, GPR41, GPR43, GPR119, Takeda G protein-coupled receptor 5).Altogether, understanding the complexity and the molecular aspects linking gut microbes to health will help to set the basis for novel therapies that are already being developed.
Cited by
- Social Structure and Interactions Differentially Shape Aerotolerant and Anaerobic Gut Microbiomes in a Cooperative Breeding Species
- Gut microbiota regulates exercise-induced hormetic modulation of cognitive function
- Lactucopicrin: A Sesquiterpene Lactone with Anti-Inflammatory Activity Modulates the Crosstalk between NF-kB and AHR Pathways
- Microbiome composition and presence of cultivable commensal groups of Southern Tamanduas (Tamandua tetradactyla) varies with captive conditions
- Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation
- Navigating contradictions: Salmonella Typhimurium chemotactic responses to conflicting effector stimuli
- Effects of a novel synbiotic intervention on abdominal visceral fat reductions and gut microbiota in overweight and obese adults: A randomized, double-blind, placebo-controlled trial
- Gut microbiome of New Zealand abalone ( <i>Haliotis iris</i> ): a Chatham Islands case study
- International consensus statement on microbiome testing in clinical practice
- Association between the gut microbiome and neurodevelopmental outcomes in infants with congenital heart disease: A prospective cohort study
- Mucosal immune responses and intestinal microbiome associations in wild spotted hyenas (Crocuta crocuta)
- Impacts of maternal microbiota and microbial metabolites on fetal intestine, brain, and placenta
- From microbiome to metabolism: Bridging a two-decade translational gap
- The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies
- A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
- Microbiota-Derived Metabolites in Developmental Programming: Bridging Early-Life Gut Microbiota to Childhood Metabolic Disorders
- From Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
- Changing Gastrointestinal Transit Time Alters Microbiome Composition and Bile Acid Metabolism: A Cross‐Over Study in Healthy Volunteers
- Dietary legumes and gut microbiome: a comprehensive review
- Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories
- Gut microbiota development across the lifespan: Disease links and health‐promoting interventions
- Promoting Microbiology Literacy and Holistic Health: <scp>IMiLI</scp> and <scp>IMiLI</scp> ‐ <scp>SAC</scp> Perspectives on Microbes, Diet, Lifestyle and Society—A 5‐Year Journey
- Gut microbiota‐derived tryptophan metabolites improve total parenteral nutrition‐associated infections by regulating Group 3 innate lymphoid cells
- Oral microbiota signatures in obesity with or without acanthosis nigricans in a Chinese cohort
- The microbiome: An actor or stage for the beneficial action of probiotics, prebiotics, synbiotics, and postbiotics?
- Imbalance in gut microbial interactions as a marker of health and disease
- Deciphering oxidative stress responses in human gut microbes and fecal microbiota: a cultivation-based approach
- The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. [europepmc]
- Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts. [europepmc]
- Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. [europepmc]
- Microbial transmission, colonisation and succession: from pregnancy to infancy. [europepmc]
- The neurobiology of irritable bowel syndrome. [europepmc]
- Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome? [europepmc]
- The exposome and liver disease - how environmental factors affect liver health. [europepmc]
- Emerging issues in probiotic safety: 2023 perspectives. [europepmc]
- Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections. [europepmc]
- Gut Microbiome-Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders. [europepmc]
- Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus. [europepmc]
- The Influence of Gut Microbiota on Oxidative Stress and the Immune System. [europepmc]
- Gut microbiota bridges dietary nutrients and host immunity. [europepmc]
- Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. [europepmc]
- Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. [europepmc]
- Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. [europepmc]
- The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective. [europepmc]
- Gut liver brain axis in diseases: the implications for therapeutic interventions. [europepmc]
- Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. [europepmc]
- Paternal microbiome perturbations impact offspring fitness. [europepmc]
- Critical role of the gut microbiota in immune responses and cancer immunotherapy. [europepmc]
- The influence of Akkermansia muciniphila on intestinal barrier function. [europepmc]
- A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation. [europepmc]
- What defines a healthy gut microbiome? [europepmc]
- Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. [europepmc]
Related